Acquired persistently complete remission by decitabine-based treatment for acute myeloid leukemia with the <i>MLL-SEPT9</i> fusion gene.

Wang, Fujue; Chen, Yingying; Jiang, Nenggang; Gong, Shuaige; Cao, Tingyong; Yuan, Jin; Liu, Jiazhuo; Xie, Liping; Wu, Yu; Jia, Yongqian

Acquired persistently complete remission by decitabine-based treatment for acute myeloid leukemia with the MLL-SEPT9 fusion gene.

Wang, Fujue; Chen, Yingying; Jiang, Nenggang; Gong, Shuaige; Cao, Tingyong; Yuan, Jin; Liu, Jiazhuo; Xie, Liping; Wu, Yu; Jia, Yongqian.

Afiliação

Wang F; Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, China.
Chen Y; Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, China.
Jiang N; Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China.
Gong S; Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, China.
Cao T; Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, China.
Yuan J; Department of Hematology, The People's Hospital of Longquanyi District, Chengdu, China.
Liu J; Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, China.
Xie L; Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, China.
Wu Y; Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, China.
Jia Y; Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, China.

Leuk Lymphoma ; 60(13): 3304-3307, 2019 12.

Article em En | MEDLINE | ID: mdl-31256701

Assuntos

Antimetabólitos Antineoplásicos/uso terapêutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Decitabina/uso terapêutico; Leucemia Mieloide Aguda/tratamento farmacológico; Proteínas de Fusão Oncogênica/genética; Antimetabólitos Antineoplásicos/farmacologia; Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia; Cromossomos Humanos Par 11/genética; Metilação de DNA/efeitos dos fármacos; Decitabina/farmacologia; Histona-Lisina N-Metiltransferase/genética; Humanos; Cariotipagem; Leucemia Mieloide Aguda/diagnóstico; Leucemia Mieloide Aguda/genética; Leucemia Mieloide Aguda/patologia; Masculino; Proteína de Leucina Linfoide-Mieloide/genética; Septinas/genética; Translocação Genética; Resultado do Tratamento; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Fusão Oncogênica / Decitabina / Antimetabólitos Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google